Handelsbanken Fonder AB lessened its holdings in Genpact Limited (NYSE:G – Free Report) by 2.8% during the 2nd quarter, Holdings Channel reports. The firm owned 41,800 shares of the business services provider’s stock after selling 1,200 shares during the quarter. Handelsbanken Fonder AB’s holdings in Genpact were worth $1,840,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. LSV Asset Management acquired a new position in shares of Genpact during the 2nd quarter worth approximately $71,592,000. Clark Capital Management Group Inc. purchased a new position in Genpact during the first quarter worth $64,842,000. Nordea Investment Management AB raised its holdings in shares of Genpact by 60.2% in the second quarter. Nordea Investment Management AB now owns 2,617,255 shares of the business services provider’s stock worth $114,924,000 after acquiring an additional 983,774 shares during the last quarter. Jupiter Asset Management Ltd. lifted its position in shares of Genpact by 601.5% in the second quarter. Jupiter Asset Management Ltd. now owns 1,081,109 shares of the business services provider’s stock valued at $47,580,000 after acquiring an additional 927,003 shares in the last quarter. Finally, Ameriprise Financial Inc. lifted its position in shares of Genpact by 109.8% in the first quarter. Ameriprise Financial Inc. now owns 1,615,220 shares of the business services provider’s stock valued at $81,375,000 after acquiring an additional 845,393 shares in the last quarter. 96.03% of the stock is currently owned by institutional investors and hedge funds.
Genpact Stock Down 0.9%
Shares of G opened at $44.25 on Thursday. Genpact Limited has a fifty-two week low of $37.49 and a fifty-two week high of $56.76. The company’s fifty day moving average is $41.33 and its two-hundred day moving average is $43.00. The firm has a market cap of $7.63 billion, a PE ratio of 14.27, a price-to-earnings-growth ratio of 1.43 and a beta of 0.85. The company has a quick ratio of 1.51, a current ratio of 1.51 and a debt-to-equity ratio of 0.33.
Genpact Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 23rd. Stockholders of record on Tuesday, December 9th will be issued a dividend of $0.17 per share. The ex-dividend date is Tuesday, December 9th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.5%. Genpact’s payout ratio is presently 21.94%.
Insider Buying and Selling at Genpact
In other news, CEO Balkrishan Kalra sold 55,000 shares of the stock in a transaction on Thursday, September 11th. The shares were sold at an average price of $43.36, for a total value of $2,384,800.00. Following the completion of the sale, the chief executive officer owned 295,246 shares of the company’s stock, valued at $12,801,866.56. This represents a 15.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Piyush Mehta sold 76,902 shares of Genpact stock in a transaction on Friday, September 12th. The shares were sold at an average price of $42.58, for a total transaction of $3,274,487.16. Following the transaction, the senior vice president owned 134,880 shares in the company, valued at $5,743,190.40. The trade was a 36.31% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 161,183 shares of company stock worth $6,970,760 in the last quarter. Company insiders own 3.07% of the company’s stock.
Analyst Ratings Changes
G has been the subject of a number of recent research reports. JPMorgan Chase & Co. dropped their price objective on Genpact from $55.00 to $50.00 and set a “neutral” rating for the company in a research report on Wednesday, August 20th. Weiss Ratings reiterated a “hold (c)” rating on shares of Genpact in a report on Wednesday, October 8th. Wall Street Zen raised shares of Genpact from a “hold” rating to a “buy” rating in a research note on Saturday, November 15th. Needham & Company LLC lifted their target price on shares of Genpact from $50.00 to $53.00 and gave the stock a “buy” rating in a research note on Friday, August 8th. Finally, Citigroup upgraded Genpact to a “hold” rating in a report on Thursday, October 23rd. Three investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat, Genpact has an average rating of “Hold” and a consensus price target of $51.13.
Check Out Our Latest Stock Analysis on G
Genpact Company Profile
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Recommended Stories
- Five stocks we like better than Genpact
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Why Gold Loves Trump as Much as Trump Loves Gold
- How to Buy Gold Stock and Invest in Gold
- Google’s Gemini 3 Sends Broadcom Soaring: TPUs Take Center Stage
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Palantir Isn’t Just Riding the AI Boom—It’s Orchestrating It
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
